MGI Tech Co., Ltd. Stock

Equities

688114

CNE100005PC8

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
59 CNY -4.08% Intraday chart for MGI Tech Co., Ltd. +1.37% -31.41%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.38B 467M Sales 2025 * 4.56B 631M Capitalization 25.35B 3.51B
Net income 2024 * -297M -41.11M Net income 2025 * 88M 12.18M EV / Sales 2024 * 5.98 x
Net cash position 2024 * 5.16B 715M Net cash position 2025 * 2.57B 356M EV / Sales 2025 * 5 x
P/E ratio 2024 *
-82.3 x
P/E ratio 2025 *
235 x
Employees 2,867
Yield 2024 *
0.04%
Yield 2025 *
0.17%
Free-Float 29.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.08%
1 week+1.37%
Current month+1.37%
1 month+0.84%
3 months-20.37%
6 months-29.54%
Current year-31.41%
More quotes
1 week
56.53
Extreme 56.53
63.15
1 month
50.30
Extreme 50.3
63.15
Current year
50.30
Extreme 50.3
87.86
1 year
50.30
Extreme 50.3
106.68
3 years
50.30
Extreme 50.3
148.84
5 years
50.30
Extreme 50.3
148.84
10 years
50.30
Extreme 50.3
148.84
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 16-03-31
Director of Finance/CFO 55 19-11-30
President 56 18-06-30
Members of the board TitleAgeSince
Director/Board Member 57 23-09-19
Chairman 70 20-06-22
Director/Board Member 42 23-09-19
More insiders
Date Price Change Volume
24-05-09 59 -4.08% 1 775 550
24-05-09 61.51 +2.86% 2,940,988
24-05-08 59.8 +3.64% 3,674,492
24-05-07 57.7 +0.65% 2,071,902
24-05-06 57.33 -1.49% 2,423,355

End-of-day quote Shanghai S.E., May 09, 2024

More quotes
MGI Tech Co Ltd is a China-based company mainly engaged in the research and development, production and sales of related products such as instruments and equipment, reagents and consumables. The Company is mainly engaged in three businesses. The gene sequencer business mainly includes the development of small and medium-sized desktop sequencers and large and ultra-large sequencers, and the establishment of a full range of multi-model product matrix to meet the needs of users in different application scenarios. The laboratory automation business mainly includes the development of automated sample processing systems, laboratory automation pipelines, sample processing reagent consumables and other laboratory automation products. The new business mainly includes cytomic solutions, remote ultrasound robots and bioinformation Technology (BIT) products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
61.51 CNY
Average target price
83.09 CNY
Spread / Average Target
+35.08%
Consensus
  1. Stock Market
  2. Equities
  3. 688114 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW